GOLDENWELL BIOTECH, INC. GWLL
OTC · stock · Food and Kindred Products · website · IPO 2021-12-07
GOLDENWELL BIOTECH, INC. statistics & valuation
Market cap$51.5M
Net margin-94602.9%
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Gross margin | 46.0% | 28.5% | 52.7% | 52.5% | — | — |
| Operating margin | -88559.7% | -4949.8% | -2060.9% | -740.7% | — | — |
| Net margin | -94602.9% | -5015.4% | -2060.9% | -732.6% | — | — |
| Return on assets | -58.7% | -51.5% | -396.6% | -25.4% | -2.5% | -0.9% |
| Return on equity | 278.4% | -138.5% | -488.6% | -38.8% | -2.5% | -0.9% |
| Debt / equity | -3.68× | 0.55× | — | — | — | — |
Source: SEC EDGAR filings · CIK 0001800373 · US · as of 2024-12-31. facts plus Stocktoria's own computed scores — not investment advice.